No driver behind the wheel? Targeting transcription in cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26406367.
- Also identified by DOI 10.1016/j.cell.2015.09.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Exploiting the dependence of cancer cells on transcription can be used as an effective strategy for targeting aggressive and therapeutically recalcitrant tumors. Wang et al. show that inhibiting transcription using THZ1, a small-molecule inhibitor of cyclin-dependent kinase CDK7, induces apoptotic cell death in triple-negative breast cancers.
Medical subject headings
- Cyclin-Dependent Kinases
- Gene Expression Regulation, Neoplastic
- Transcription, Genetic
- Triple Negative Breast Neoplasms